ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,455,126 | +46.1% | 11,096 | +15.8% | 0.01% | +42.9% |
| Q2 2023 | $3,732,834 | -7.9% | 9,578 | -11.9% | 0.01% | -12.5% |
| Q1 2023 | $4,051,435 | -4.5% | 10,874 | -2.9% | 0.01% | -11.1% |
| Q4 2022 | $4,241,381 | +26.6% | 11,196 | +18.0% | 0.01% | +28.6% |
| Q3 2022 | $3,349,000 | +29.9% | 9,486 | +39.4% | 0.01% | +16.7% |
| Q2 2022 | $2,578,000 | +130.8% | 6,803 | +92.0% | 0.01% | +200.0% |
| Q1 2022 | $1,117,000 | +31.4% | 3,544 | +46.0% | 0.00% | 0.0% |
| Q4 2021 | $850,000 | – | 2,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |